Keld Kaltoft

1.9k total citations
30 papers, 1.6k citations indexed

About

Keld Kaltoft is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Keld Kaltoft has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 12 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Keld Kaltoft's work include Immunotherapy and Immune Responses (8 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Cutaneous lymphoproliferative disorders research (7 papers). Keld Kaltoft is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Cutaneous lymphoproliferative disorders research (7 papers). Keld Kaltoft collaborates with scholars based in Denmark, United Kingdom and United States. Keld Kaltoft's co-authors include Niels Ødum, Jørgen Agnholt, Kristian Thestrup‐Pedersen, Mette Nielsen, Arne Svejgaard, Carsten Geisler, Christine Brender, Jesper Zeuthen, Elaine Wilson and Lars Skriver and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Keld Kaltoft

30 papers receiving 1.5k citations

Peers

Countries citing papers authored by Keld Kaltoft

Since Specialization

Citations

This map shows the geographic impact of Keld Kaltoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keld Kaltoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keld Kaltoft more than expected).

Fields of papers citing papers by Keld Kaltoft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keld Kaltoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keld Kaltoft. The network helps show where Keld Kaltoft may publish in the future.

Co-authorship network of co-authors of Keld Kaltoft

This figure shows the co-authorship network connecting the top 25 collaborators of Keld Kaltoft. A scholar is included among the top collaborators of Keld Kaltoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keld Kaltoft. Keld Kaltoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709) 2009 ·Cytotherapy ·Tania Køllgaard, (unknown), Henrik Schmidt, Keld Kaltoft, Tina Seremet, Mads Hald Andersen, Hans von der Maase, Per thor Straten, Sine Reker Hadrup	2
2	Increased Sensitivity to Interferon-α in Psoriatic T Cells 2005 ·Journal of Investigative Dermatology ·Karsten W. Eriksen, Paola Lovato, Lone Skov, Thorbjørn Krejsgaard, Keld Kaltoft, Carsten Geisler, Niels Ødum	69
3	The effect of etanercept and infliximab on the production of tumour necrosis factor α, interferon-γ and GM-CSF in in vivo activated intestinal T lymphocyte cultures 2003 ·Cytokine ·Jørgen Agnholt, Jens Frederik Dahlerup, Keld Kaltoft	42
4	Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease 2003 ·Journal of Biological Chemistry ·Paola Lovato, Christine Brender, Jørgen Agnholt, Jens Kelsen, Keld Kaltoft, Arne Svejgaard, Karsten W. Eriksen, Anders Woetmann, Niels Ødum	160
5	SHP2 REGULATES IL-2 INDUCED MAPK ACTIVATION, BUT NOT Stat3 OR Stat5 TYROSINE PHOSPHORYLATION, IN CUTANEOUS T CELL LYMPHOMA CELLS 2002 ·Cytokine ·Johannes Brockdorff, Anders Woetmann, Tomas Mustelin, Keld Kaltoft, Qian Zhang, Mariusz A. Wasik, Carsten Röpke, Niels Ødum	12
6	T-cell vaccination in Crohn's disease: principles and presentation of the first two cases 2002 ·PubMed ·Jørgen Agnholt, Keld Kaltoft, (unknown), Jens Frederik Dahlerup	5
7	INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE 2001 ·Cytokine ·Jørgen Agnholt, Keld Kaltoft	70
8	Gab2 Is Phosphorylated on Tyrosine upon Interleukin-2/Interleukin-15 Stimulation in Mycosis-fungoides-Derived Tumor T Cells and Associates Inducibly with SHP-2 and Stat5a 2001 ·PubMed ·Johannes Brockdorff, Haihua Gu, Tomas Mustelin, Keld Kaltoft, Carsten Geisler, Carsten Röpke, Niels Ødum	14
9	In situ Activated Intestinal T Cells Expanded in vitro – without Addition of Antigen – Produce IFN-γ and IL-10 and Preserve Their Function during Growth 2001 ·PubMed ·Jørgen Agnholt, Keld Kaltoft	15
10	Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries 2001 ·European Journal of Immunology ·Thomas Linnemann, (unknown), Sylke Gellrich, Karl‐Heinz Wiesmüller, Keld Kaltoft, Wolfram Sterry, Peter Walden	42
11	Microdissection and reverse painting in a melanoma cell line 2001 ·Cancer Genetics and Cytogenetics ·(unknown), (unknown), (unknown), Keld Kaltoft	9
12	Cytokine-Driven Immortalization of in vitro Activated Human T Lymphocytes 1998 ·PubMed ·Keld Kaltoft	18
13	Appearance of isochromosome 18q can be associated with in vitro immortalization of human T lymphocytes 1995 ·Cancer Genetics and Cytogenetics ·Keld Kaltoft, (unknown), (unknown), Kristian Thestrup‐Pedersen	13
14	In vitro genetically aberrant T cell clones with continuous growth is associated with atopic dermatitis 1994 ·Journal of Investigative Dermatology ·Keld Kaltoft, Kristian Thestrup‐Pedersen	1
15	Cytogenetic Findings in Cell Lines from Cutaneous T-Cell Lymphoma 1994 ·Dermatologic Clinics ·Keld Kaltoft, (unknown), Kristian Thestrup‐Pedersen	53
16	Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides 1992 ·In Vitro Cellular & Developmental Biology - Animal ·Keld Kaltoft, S Bisballe, Thomas Dyrberg, Esper Boel, P. B. Rasmussen, Kristian Thestrup‐Pedersen	114
17	Immunocytochemical identification of the human α2-macrogiobulin receptor in monocytes and fibroblasts: Monoclonal antibodies define the receptor as a monocyte differentiation antigen 1990 ·Experimental Cell Research ·Søren K. Moestrup, Keld Kaltoft, (unknown), Søren L. Pedersen, (unknown), Erik Christensen	54
18	Development of Cutaneous Pseudolymphoma Following Ciclosporin Therapy of Actinic Reticuloid 1988 ·Dermatology ·Kristian Thestrup‐Pedersen, Claus Zachariae, Keld Kaltoft, Gorm Pallesen, H. Søgaard	22
19	Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody 1982 ·Biochemistry ·Lars S. Nielsen, (unknown), Lars Skriver, Elaine Wilson, Keld Kaltoft, Jesper Zeuthen, (unknown)	220
20	Search for revertants of the glutamine mischarging mutants of Escherichia coli su⁺3 tyrosine suppressor tRNA that are able to insert tyrosine at the site of amber mutation 1977 ·Nucleic Acids Research ·Julio E. Celis, (unknown), Keld Kaltoft, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact